viernes, 21 de agosto de 2026
Focal therapy for localized prostate cancer has divided physicians. Will new data change minds? Recent study found 10-year survival was comparable to surgery or radiation, with fewer side effects
https://www.statnews.com/2026/08/21/focal-therapy-prostate-cancer-still-experimental-or-viable-alternative/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-991g3erGfAD2icG4rzlBwFVgVi_c46DHNE0NrFq7iVyqptCtI1a4dll-OvrqBIFTnhOwn6zwlH2Vj0pG8-rrHqBJHrIw&_hsmi=434260558&utm_content=434260558&utm_source=hs_email
By Annalisa MerelliAug. 21, 2026
Contributing Writer
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario